Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab

PURPOSE: To determine the risk factors associated with sustained intraocular pressure (IOP) rise in patients enrolled in the treat and extend (T&E) protocol receiving aflibercept/ranibizumab therapy for 3 years. DESIGN: Retrospective, observational chart review. Setting. Multicentric. Patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Bilgic, Alper, Kodjikian, Laurent, Chhablani, Jay, Sudhalkar, Anand, Trivedi, Megha, Vasavada, Viraj, Vasavada, Vaishali, Vasavada, Shail, Srivastava, Samaresh, Bhojwani, Deepak, Sudhalkar, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995478/
https://www.ncbi.nlm.nih.gov/pubmed/32051764
http://dx.doi.org/10.1155/2020/7462098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995478/
https://www.ncbi.nlm.nih.gov/pubmed/32051764
http://dx.doi.org/10.1155/2020/7462098

Ejemplares similares